{"prompt": "['Date: June 30, 2020', 'Principal Investigator: James Black', 'Application Number: IRB00075706', '4.', 'Study Procedures', 'a. Study design, including the sequence and timing of study procedures', '(distinguish research procedures from those that are part of routine care).', 'Patient Population', 'The study will evaluate 16 patients with type I, II, III, and V thoracoabdominal aneurysms', 'meeting protocol inclusion criteria. The patient population includes both male and female', 'patients greater than 18 years old with a life expectancy of at least one year.', 'Study Type and Duration', 'This study is a prospective, single-center, non-randomized, multi-arm study to evaluate the', 'therapeutic benefit of the Valiant Thoracoabdominal Stent Graft System. A total of 16 patients', '(10 in the primary ptudy arm; 6 in the expanded selection criteria arm) will be enrolled in the', 'study for treatment with the Valiant Thoracoabdominal Stent Graft System. The duration of the', 'Investigation is anticipated as follows:', 'Time to Complete Enrollment: 24 months', 'Subject Follow-up Time: 5 years from last subject enrollment', 'Total Duration Time: 7 years', 'Intended Use', 'The Valiant Thoracoabdominal Stent Graft System is indicated for the endovascular treatment', 'of thoracoabdominal aortic aneurysm (Crawford Type 1, 2, 3 and 5) in patients with the', 'following characteristics:', 'o', 'An aneurysm with a maximum diameter of > 5.5 cm or 2 times the normal diameter just', 'proximal to the aneurysm using orthogonal (i.e., perpendicular to the centerline) measurements', 'Aneurysm with a history of growth > 0.5 cm in 6 months', 'Saccular aneurysm deemed at significant risk for rupture', 'Symptomatic aneurysm greater than or equal to 4.5 cm', 'Axillary or brachial and iliac or femoral access vessel morphology that is compatible with', 'vascular access techniques, devices or accessories, with or without use of a surgical conduit', 'Proximal landing zone for the thoracic bifurcation stent graft that has:', '> 2.5 cm of healthy/non-diseased tissue including both native tissue and previously', 'placed graft, (neck) distal to the left subclavian artery (LSA) diameter in the range of', '26-42 mm', 'Adequate distance from the celiac artery, in order to accommodate cannulation from', 'the antegrade access point when considering the total deployed length of the thoracic', 'bifurcation and visceral manifold', 'o', 'o', 'Iliac artery or aortic distal fixation site, including both native tissue and previously', 'placed graft, greater than or equal to 15 mm in length and diameter in the range of 8 - 25 mm', 'Age: > 18 years old', 'Life expectancy: > 1 year', 'Patient Enrollment and Screening', 'The investigator will assess potential study subjects with thoracoabdominal aortic', 'aneurysms for their suitability for enrollment into the clinical study. If the patient appears to meet', 'eligibility criteria, either for the primary study arm or the expanded selection arm, then the', 'investigator or clinical study coordinator will discuss the study with the patient and provide patient', 'education materials to adequately inform the patient of potential risks and benefits, required follow-', 'up procedures, and answer any questions. The clinical study coordinator will facilitate the informed', 'Version 4.0', 'Page 21 of 54']['Date: June 30, 2020', 'Principal Investigator: James Black', 'Application Number: IRB00075706', 'consent process. After the patient has been properly consented, the patient will complete additional', 'screening procedures that need to be completed. If the patient does not sign the informed consent,', 'they will not be enrolled in the study. Information to be collected for screening includes:', 'Patient demographics', 'Medical history', 'Current health status', 'Physical examination', 'Ankle Brachial Index (ABI)', 'Pregnancy test (for female patients of childbearing age)', 'CTA or CT with contrast of the chest, abdomen and pelvis if renal function allows. If renal', 'function does not allow CT with contrast, an alternative contrast-enhanced imaging modality or, at a', 'minimum, CT non-contrast in conjunction with Duplex ultrasound will be used at physician', 'discretion to evaluate:', 'Access vessels for compatibility with vascular access techniques', 'Obstructive stenting of the visceral vessels', 'Vessels diameters suitable for use with the Valiant Thoracoabdominal Stent Graft System', 'Aneurysm rupture', 'Dissection', 'Patency of left subclavian artery, hypogastric arteries, lumbar arteries, and all four visceral', 'vessels', 'Thrombus or excessive calcification in the neck of the aneurysm', 'Presence and location of any previously placed graft material', 'Complete blood count to evaluate white blood cells, hemoglobin, and platelets', 'Basic metabolic panel to evaluate creatinine', 'For patients with a history of smoking a pulmonary function test', 'Cardiac clearance', 'Case Planning', 'From the pre-op CT, the surgeon will make the following measurements to size the endografts.', '1. Length of the proximal seal zone, the distance required to land the thoracic bifurcation stent', 'graft, this requires > 2.5 cm section of healthy aorta or previously placed graft material, distal to', 'the left subclavian artery or > 2.5cm of surgical graft.', '2. Diameter of the proximal landing zone to define the required diameter of the thoracic', 'bifurcation stent graft. The diameter of the thoracic bifurcation stent graft should be 10-15%', 'larger than the diameter of the aorta to proper oversize the stent graft.', '3. Maximum aortic diameter within the treated aorta', '4. Distance from the top of the celiac to the top of the most cephalic renal.', '5. Distance from the top of the proximal seal zone to the takeoff of the celiac.', '6. Distance from the top of the celiac to the SMA.', '7. Angulation at the mid-thoracic aorta.', '8. Angulation at the diaphragm.', '9. Angulation at the renal arteries.', '10. Distance from the right renal to the ispilateral internal iliac artery.', '11. Distance from lower renals to aortic bifurcation.', '12. Diameter of the branch vessels (celiac, SMA, left renal, and right renal) to determine the', 'diameter bridging stents needed and percent patency.', '13. Diameter of the right and left common iliac to secure the distal seal of the infrarenal bifurcation.', '14. Diameter of the distal aorta to secure the distal seal in aorta', 'Version 4.0', 'Page 22 of 54']\n\n###\n\n", "completion": "END"}